Buy Recommendation Issued On TRAW By H.C. Wainwright
Source: KlickAnalytics
2025-12-03 06:15:11 ET
Historical Analyst Recommendations
Latest 10 recommendations| Report Date | Analyst Company | Action | Previous Grade | New Grade | Price when posted | ...
Traws Pharma Inc.
NASDAQ: TRAW
TRAW Trading
3.14% G/L:
$1.97 Last:
59,512 Volume:
$1.73 Open:
TRAW Latest News
February 19, 2026 07:30:00 am
Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
January 26, 2026 08:30:00 am
Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
TRAW Stock Data
$15,422,373
6,872,146
2.64%
11
N/A
Biotechnology & Life Sciences
Healthcare
US
Newtown
